Company Nord Pharma Srl with Fiscal Code 14477809
recorded a turnover of 2024 of
958.097,
with a net profit of
255.917
and having an average number of employees of
6.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Nord Pharma Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
766.701
838.498
863.914
861.965
902.085
871.704
812.047
936.460
961.352
958.097
Total Income - EUR
767.483
839.475
864.239
862.438
902.842
872.092
812.465
940.669
963.061
958.767
Total Expenses - EUR
600.262
642.013
659.862
675.639
683.949
640.013
605.807
700.928
648.826
653.118
Gross Profit/Loss - EUR
167.221
197.462
204.377
186.799
218.893
232.080
206.658
239.741
314.235
305.649
Net Profit/Loss - EUR
134.738
163.385
169.822
178.174
209.864
224.020
199.265
231.246
276.577
255.917
Employees
12
13
13
10
8
8
7
6
6
6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 0.2%, from 961.352 euro in the year 2023, to 958.097 euro in 2024.
The Net Profit decreased by -19.114 euro, from 276.577 euro in 2023, to 255.917 in the last year.
Check the financial reports for the company - Nord Pharma Srl
Financial Rating - NORD PHARMA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Nord Pharma Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Nord Pharma Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Nord Pharma Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Nord Pharma Srl - CUI 14477809
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
228.082
235.116
215.403
210.367
190.237
168.079
152.805
142.258
224.768
204.547
Current Assets
704.227
723.964
890.464
874.009
695.224
866.454
851.557
612.287
805.823
705.835
Inventories
53.367
59.049
72.212
68.657
66.691
67.416
65.979
89.505
89.448
98.914
Receivables
290.492
306.371
293.702
283.067
280.979
281.021
292.976
398.221
440.695
457.576
Cash
360.368
358.543
524.550
522.286
347.553
518.017
492.602
124.561
275.680
149.345
Shareholders Funds
714.561
166.046
169.866
344.923
550.916
763.148
829.952
603.468
870.503
623.253
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
226.070
803.442
946.822
749.632
345.215
280.944
183.900
160.517
169.376
297.088
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
705.835 euro in 2024 which includes Inventories of
98.914 euro, Receivables of
457.576 euro and cash availability of
149.345 euro.
The company's Equity was valued at
623.253 euro, while total Liabilities amounted to
297.088 euro.
Equity decreased by -242.385 euro, from 870.503 euro in 2023, to 623.253 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Nord Pharma Srl